Carling Tobias, Udelsman Robert
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Thyroid. 2005 Jun;15(6):583-7. doi: 10.1089/thy.2005.15.583.
Follicular neoplasms of the thyroid are usually diagnosed following fine-needle aspiration (FNA) biopsy of a dominant thyroid nodule. An FNA diagnosis of a follicular neoplasm represents a heterogeneous group of lesions including benign follicular hyperplasia, follicular adenomas, follicular carcinomas, and the follicular variant of papillary carcinoma. Hürthle cell neoplasms are also often included in this group. Because the criteria for malignancy in both follicular and Hürthle cell neoplasms requires vascular or capsular invasion seen on permanent histology, the majority of these patients undergo surgical resection. Intraoperative frozen section analysis of follicular neoplasms rarely renders informative information. Approximately 20% of these lesions prove to be malignant and for lesions greater than 1.0 cm in size, the majority of surgeons and endocrinologists recommend a total thyroidectomy. Postoperative treatment generally includes therapeutic doses of 131I for follicular carcinomas.
甲状腺滤泡性肿瘤通常在对甲状腺优势结节进行细针穿刺(FNA)活检后得以诊断。FNA诊断为滤泡性肿瘤代表了一组异质性病变,包括良性滤泡增生、滤泡性腺瘤、滤泡性癌以及乳头状癌的滤泡变体。许特莱细胞肿瘤通常也包含在这一组中。由于滤泡性和许特莱细胞肿瘤的恶性标准都需要在永久组织学检查中见到血管或包膜侵犯,因此这些患者中的大多数都接受手术切除。滤泡性肿瘤的术中冰冻切片分析很少能提供有用信息。这些病变中约20%被证明是恶性的,对于直径大于1.0厘米的病变,大多数外科医生和内分泌学家建议行全甲状腺切除术。术后治疗通常包括对滤泡性癌给予治疗剂量的131I。